在患有脊椎关节炎的患者中,系统性自身炎症表现
Carla Gaggiano1, Mojca Zajc Avramovič2, Antonio Vitale1
1Rheumatology Unit, Department of Medical Sciences, Surgery and Neuroscience, University of Siena and Azienda Ospedaliero-Universitaria Senese, Viale Mario Bracci 16, 53100 Siena, Italy.
Joint bone spine
|September 14, 2024
概括
与系统性自身炎症症状 (S-SpA) 相关的脊椎关节炎与SPA和斯蒂尔病 (SD) 相比呈现出明显的特征. 对于患有自身炎症性疾病的患者来说,早期对SPA进行检查至关重要.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 系统性自身炎症性疾病 系统性自身炎症性疾病
背景情况:
- 脊椎关节炎 (SpA) 包含一组炎症性疾病.
- 自动炎症症状可以与SPA重叠,需要区分.
- 斯蒂尔病 (SD) 是一种独特的全身性炎症状况.
研究的目的:
- 以系统性自发炎症症状 (S-SpA) 来表征脊椎关节炎.
- 为了比较SPA的临床和成像特征,有和没有系统性自身炎症症状.
- 根据自身炎症特征来区分S-SpA与斯蒂尔病 (SD).
主要方法:
- 追溯观察性研究设计.
- 包括被诊断患有S-SpA,SD或SpA的成人和儿科患者.
- 分析收集的临床数据进行比较评估.
主要成果:
- 与S-SpA患者相比,与S-SpA患者相比,S-SpA患者表现出独特的外周关节炎,肠炎和肌炎的模式.
- 在S-SpA和SD之间观察到发烧,皮疹和胃肠道症状的明显差异.
- 在SD患者中,炎症标志物 (ESR,CRP,WBC) 显着更高.
- 与SD相比,在S-SpA中对皮质类固醇和甲醇的治疗反应对全身症状不那么有利.
- 在SD的全身阶段,完整的皮质类固醇反应降低了发展SPA的可能性.
结论:
- 在表现出自身炎症表现的患者中,应考虑脊椎关节炎.
- 区分S-SpA和SD对于适当的管理是很重要的.
- 需要对未分化的自身炎症性疾病和SD进行进一步的研究.
相关概念视频
01:29Autoimmune Disorders
396
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
396
01:30Inflammatory Bowel Disease II: Crohn's Disease
201
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
201
01:17Chronic Bowel Disorders: Introduction
410
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
410
01:24T Cell Types and Functions
961
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
961
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
153
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
153
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
120
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
120